AbbVie (ABBV - Get Report) was initiated with a hold rating at Deutsche Bank. $63 price target. The company remains highly levered to Humira, which has an uncertain amount of exclusivity, Deutsche said.
Cohen & Steers (CNS - Get Report) was upgraded to buy from underperform at Bank of America/Merrill Lynch. $37 price target. The company is delivering organic growth in a tough environment, analysts said.
ITC (ITC) was downgraded to hold from buy at Deutsche Bank. The valuation isn't as attractive, based on a $43 price target, Deutsche said.